✦ LIBER ✦

Design of adaptive two-stage double-arm clinical trials for dichotomous variables

✍ Scribed by Zhiwei Jiang; Fubo Xue; Chanjuan Li; Ling Wang; Hongwei Cai; Chunmao Zhang; Jielai Xia

Book ID: 116350869
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 305 KB
Volume: 31
Category: Article
ISSN: 1551-7144
DOI: 10.1016/j.cct.2010.02.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adaptive Two-Stage Designs for Single-Ar

Adaptive Two-Stage Designs for Single-Arm Phase IIA Cancer Clinical Trials

✍ Yong Lin; Weichung J. Shih 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Flexible design of two-stage adaptive pr

Flexible design of two-stage adaptive procedures for phase III clinical trials

✍ Tatsuki Koyama 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 271 KB

A Bayesian adaptive design for two-stage

A Bayesian adaptive design for two-stage clinical trials with survival data

✍ Uttam Bandyopadhyay; Atanu Biswas; Rahul Bhattacharya 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 336 KB

A covariate-adjusted adaptive design for

A covariate-adjusted adaptive design for two-stage clinical trials with survival data

✍ Uttam Bandyopadhyay; Atanu Biswas; Rahul Bhattacharya 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB

A new adaptive design based on Simon's t

A new adaptive design based on Simon's two-stage optimal design for phase II clinical trials

✍ Hua Jin; Zhen Wei 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 183 KB

The application of a two-stage design fo

The application of a two-stage design for clinical trials in patients with recurrent head and neck cancer

✍ Eisenberger, Mario A. ;Ellenberg, Susan ;Leyland-Jones, Brian ;Friedman, Michael 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 620 KB

Cytotoxic chemotherapy produces modest benefits for patients with recurrent and metastatic squamous cell carcinoma of the head and neck (SCCHN). Prospective randomized clinical trials have failed to demonstrate unequivocal superiority of aggressive multidrug regimens over single agents. Despite this